Buspirone for anxiety and agitation in dementia

Journal of Psychiatry and Neuroscience

Volumn 28, Issue 6, 2003, Pages 469-

  Cooper, J P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CITALOPRAM; DONEPEZIL; HALOPERIDOL; LITHIUM CARBONATE; LOXAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; TRAZODONE; VALPROATE SEMISODIUM;

AGED; AGITATION; ALZHEIMER DISEASE; ANAMNESIS; ANXIETY DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REGIMEN; DRUG TOLERANCE; FEMALE; HUMAN; LETTER; PHARMACEUTICAL CARE; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME;

AGED; ANXIETY; BUSPIRONE; DEMENTIA; FEMALE; HUMANS; PSYCHOMOTOR AGITATION; SEROTONIN AGONISTS;

EID: 0346495980     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Mintzer JE, Brawman-Mintzer O. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry 1996; 57(Suppl 7):55-63.
2. Khouzam HR, Emes R. The use of buspirone in primary care. J Psychosoc Nurs Ment Health Serv 2002;40(7):34-41.
3. Salzman C. Treatment of agitation of late life psychosis and Alzheimer's disease. Eur Psychiatry 2001;16(Suppl 1): 25s-28s.
4. Apter JT, Allen LA. Buspirone: future directions. J Clin Psychopharmacol 1997;19(1):86-93.
5. Holzer JC, Gitelman DR, Price BH. Efficacy of buspirone in the treatment of dementia with aggression. Am J Psychiatry 1995;152(5):812.
6. Stanislav SW, Fabre T, Crismon ML, Childs A. Buspirone's efficacy in organic-induced aggression. J Clin Psychopharmacol 1994;14(2):126-30.
7. Tiller JW, Dakis JA, Shaw JM. Short-term buspirone treatment in disinhibition with dementia. Lancet 1988;2 (8609):510.